Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial

INTRODUCTION: Critical illness polyneuropathy and/or myopathy (CIPNM) is a severe complication of critical illness. Retrospective data suggest that early application of IgM-enriched intravenous immunoglobulin (IVIG) may prevent or mitigate CIPNM. Therefore, the primary objective was to assess the ef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Brunner, Richard, Rinner, Walter, Haberler, Christine, Kitzberger, Reinhard, Sycha, Thomas, Herkner, Harald, Warszawska, Joanna, Madl, Christian, Holzinger, Ulrike
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056097/
https://ncbi.nlm.nih.gov/pubmed/24088271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc13028
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak